These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 16924652)
21. Management of patients refractory to platelet transfusion--an evaluation of methods of donor selection. Schiffer CA Prog Hematol; 1987; 15():91-113. PubMed ID: 3332393 [No Abstract] [Full Text] [Related]
22. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients. Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764 [TBL] [Abstract][Full Text] [Related]
23. Effect of donor cell type on complement-dependent cytotoxicity crossmatch outcome for patients immunized against HLA class-II antigens. Arnold ML; Ensminger SM; Doxiadis II; Spriewald BM Exp Clin Transplant; 2008 Mar; 6(1):1-6. PubMed ID: 18405238 [TBL] [Abstract][Full Text] [Related]
24. 14th International HLA and Immunogenetics Workshop: report on the structural basis of HLA compatibility. Duquesnoy RJ; Claas FH Tissue Antigens; 2007 Apr; 69 Suppl 1():180-4. PubMed ID: 17445196 [TBL] [Abstract][Full Text] [Related]
25. How much residual plasma may cause TRALI? Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733 [TBL] [Abstract][Full Text] [Related]
26. The changing role of antibody testing in transplantation. Leffell MS; Montgomery RA; Zachary AA Clin Transpl; 2005; ():259-71. PubMed ID: 17424745 [TBL] [Abstract][Full Text] [Related]
27. Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients. Nikaein A; Cherikh W; Nelson K; Baker T; Leffell S; Bow L; Crowe D; Connick K; Head MA; Kamoun M; Kimball P; Klohe E; Noreen H; Rebellato L; Sell T; Sullivan K; Land G Transplantation; 2009 Feb; 87(4):557-62. PubMed ID: 19307794 [TBL] [Abstract][Full Text] [Related]
28. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Amico P; Hönger G; Mayr M; Steiger J; Hopfer H; Schaub S Transplantation; 2009 Jun; 87(11):1681-8. PubMed ID: 19502960 [TBL] [Abstract][Full Text] [Related]
29. [Application of platelet transfusion and their problems]. Ryo R; Hashimoto M; Takada S; Goto M; Yamaguchi N Nihon Naika Gakkai Zasshi; 1993 Jul; 82(7):1047-52. PubMed ID: 8228483 [No Abstract] [Full Text] [Related]
30. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Reinsmoen NL; Lai CH; Vo A; Cao K; Ong G; Naim M; Wang Q; Jordan SC Transplantation; 2008 Sep; 86(6):820-5. PubMed ID: 18813107 [TBL] [Abstract][Full Text] [Related]
31. Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches. Vaidya S Transplantation; 2008 Apr; 85(7):1046-50. PubMed ID: 18408587 [TBL] [Abstract][Full Text] [Related]
32. HLA Class II-specific antibodies can react with T cells in flow cytometry crossmatch: a case report. Heo WB; Kim CD; Won DI Transplant Proc; 2007 Dec; 39(10):3485-7. PubMed ID: 18089415 [TBL] [Abstract][Full Text] [Related]
33. Flow cytometry PRA using lymphocyte pools from random donors. Won DI; Jung HD; Jung OJ; Huh S; Suh JS Cytometry B Clin Cytom; 2007 Jul; 72(4):256-64. PubMed ID: 17205570 [TBL] [Abstract][Full Text] [Related]
34. TRALI: reducing its risk while trying to understand its causes. AuBuchon JP Transfusion; 2014 Dec; 54(12):3021-5. PubMed ID: 25496385 [No Abstract] [Full Text] [Related]
35. Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support? Duquesnoy RJ Transfusion; 2008 Feb; 48(2):221-7. PubMed ID: 18005328 [TBL] [Abstract][Full Text] [Related]
36. A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia. Nakazawa Y; Saito S; Hasegawa Y; Yanagisawa R; Sakashita K; Kamijo T; Miyazaki T; Sato S; Ikeda H; Ikebuchi K; Koike K Transfusion; 2007 Feb; 47(2):326-34. PubMed ID: 17302780 [TBL] [Abstract][Full Text] [Related]
37. Neonatal alloimmune thrombocytopenia and neutropenia associated with maternal human leukocyte antigen antibodies. Gramatges MM; Fani P; Nadeau K; Pereira S; Jeng MR Pediatr Blood Cancer; 2009 Jul; 53(1):97-9. PubMed ID: 19229975 [TBL] [Abstract][Full Text] [Related]
38. Generation of inflammatory cytokines and chemokines from peripheral blood mononuclear cells by HLA Class II antibody-containing plasma unit that was associated with severe nonhemolytic transfusion reactions. Sakagawa H; Miyazaki T; Fujihara M; Sato S; Yamaguchi M; Fukai K; Morioka M; Kato T; Azuma H; Ikeda H Transfusion; 2007 Jan; 47(1):154-61. PubMed ID: 17207244 [TBL] [Abstract][Full Text] [Related]
39. Patients benefit from the addition of KIR repertoire data to the donor selection procedure for unrelated haematopoietic stem cell transplantation. Schellekens J; Rozemuller EH; Petersen EJ; van den Tweel JG; Verdonck LF; Tilanus MG Mol Immunol; 2008 Feb; 45(4):981-9. PubMed ID: 17881057 [TBL] [Abstract][Full Text] [Related]